BioCentury | Oct 27, 2003
Company News

Dyax, Urrma deal

...antibodies to treat HIV. DYAX will use its antibody libraries to identify anti-R7V candidates, and Urrma...
...equally share commercialization rights and profits. The companies also have the option to jointly develop Urrma's...
...fee in return for a 45% interest in resulting products. Dyax Corp. (DYAX), Cambridge, Mass. Urrma Biopharma Inc....
BioCentury | Mar 17, 2003
Clinical News

Anti-R7V Diagnostic Kit: Pivotal

...Urrma began a study of its anti-R7V test in 1,450 patients. Urrma Biopharma Inc. , Montreal, Quebec Product...
BioCentury | Mar 11, 2002
Company News

Urrma management update

Urrma Biopharma Inc., Montreal, Quebec Business: Infectious diseases Hired: Luc Mainville as VP and CFO, formerly CFO of Waratah Pharmaceuticals Inc. WIR Staff Infectious...
BioCentury | Feb 4, 2002
Company News

Franc-Or Resources Corp., Urrma deal

...FOR exercised an option to purchase C$1 million (US$621,000) of Urrma stock. FOR previously invested C$2...
...has an option to invest an additional C$1 million. Franc-Or Resources Corp. (TSE:FOR), Montreal, Quebec Urrma Biopharma Inc....
Items per page:
1 - 4 of 4
BioCentury | Oct 27, 2003
Company News

Dyax, Urrma deal

...antibodies to treat HIV. DYAX will use its antibody libraries to identify anti-R7V candidates, and Urrma...
...equally share commercialization rights and profits. The companies also have the option to jointly develop Urrma's...
...fee in return for a 45% interest in resulting products. Dyax Corp. (DYAX), Cambridge, Mass. Urrma Biopharma Inc....
BioCentury | Mar 17, 2003
Clinical News

Anti-R7V Diagnostic Kit: Pivotal

...Urrma began a study of its anti-R7V test in 1,450 patients. Urrma Biopharma Inc. , Montreal, Quebec Product...
BioCentury | Mar 11, 2002
Company News

Urrma management update

Urrma Biopharma Inc., Montreal, Quebec Business: Infectious diseases Hired: Luc Mainville as VP and CFO, formerly CFO of Waratah Pharmaceuticals Inc. WIR Staff Infectious...
BioCentury | Feb 4, 2002
Company News

Franc-Or Resources Corp., Urrma deal

...FOR exercised an option to purchase C$1 million (US$621,000) of Urrma stock. FOR previously invested C$2...
...has an option to invest an additional C$1 million. Franc-Or Resources Corp. (TSE:FOR), Montreal, Quebec Urrma Biopharma Inc....
Items per page:
1 - 4 of 4